Doug VanOort | Chairman |
Mark Mallon | CEO |
Kathryn McKenzie | CFO |
George Cardoza | President, Pharma Services Division |
Bill Bonello | President, Informatics Division |
Doug Brown | Chief Strategy and Corporate Development Officer |
Clive Morris | CEO, Inivata |
David Westenberg | Guggenheim |
Brian Weinstein | William Blair |
Alex Nowak | Craig-Hallum Capital Group |
Mark Massaro | BTIG |
Tejas Savant | Morgan Stanley |
Mike Matson | Needham & Company |
Matthew Sykes | Goldman Sachs |
Derik De Bruin | Bank of America |
Andrew Cooper | Raymond James |
Good morning, ladies and gentlemen, and welcome to the NeoGenomics Second Quarter 2021 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, CEO, Mark Mallon. Sir, the floor is yours.
Thanks Kait and good morning, everyone. I'd like to welcome everyone to NeoGenomics' 2021 Second Quarter Conference Call.